Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited
Key Takeaways
- 10 units on a U-100 insulin syringe equals 0.10 mL of volume, but the milligram dose depends entirely on the medication concentration printed on your vial label
- For compounded semaglutide at 5 mg/mL, 10 units equals 0.5 mg; at 2.5 mg/mL it's 0.25 mg; at 1 mg/mL it's 0.1 mg
- For compounded tirzepatide at 10 mg/mL, 10 units equals 1 mg; at 5 mg/mL it's 0.5 mg; at 20 mg/mL it's 2 mg
- The most common dosing error with compounded GLP-1 medications is assuming "units" means the same thing across different vials, when concentration determines everything
Direct answer (40-60 words)
10 units on a U-100 insulin syringe is always 0.10 mL of liquid. The milligram dose that volume contains depends on your vial's concentration. At 5 mg/mL it's 0.5 mg. At 10 mg/mL it's 1 mg. At 25 mg/mL it's 2.5 mg. Check your vial label every time.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- Why "10 units" isn't a dose until you know the concentration
- What "units" actually measures (and what it doesn't)
- Complete conversion chart: 10 units to mg for every common semaglutide concentration
- Complete conversion chart: 10 units to mg for every common tirzepatide concentration
- How to find your vial's concentration in 15 seconds
- The math formula: converting any unit count to milligrams
- What most articles get wrong about unit-to-mg conversion
- The three scenarios where 10 units becomes a dangerous dose
- When 10 units is too small to draw accurately
- Clinical pattern: why concentration confusion peaks during pharmacy switches
- FAQ
- Sources
Why "10 units" isn't a dose until you know the concentration
A patient calls their provider and says, "I took 10 units like the instructions said, but I'm having severe nausea." The provider asks, "What's the concentration on your vial?" The patient says, "I don't know, it just says 10 units on the instruction sheet."
This conversation happens multiple times per week in compounded GLP-1 telehealth. The problem is that "10 units" describes syringe volume, not medication dose. It's the equivalent of saying "I took one spoonful" without specifying whether the spoon held water, honey, or hot sauce.
The U-100 insulin syringe is a volume-measuring device. The "100" in U-100 means the syringe is calibrated for U-100 insulin, where 100 units of insulin activity fits in 1 mL of liquid. Each marking on the syringe represents 0.01 mL (one hundredth of a milliliter). When you draw to the 10-unit mark, you've drawn 0.10 mL of whatever liquid is in the vial.
How many milligrams of medication that 0.10 mL contains depends on the concentration, which is the number of milligrams dissolved per milliliter. A 5 mg/mL vial has 5 milligrams in every milliliter. A 25 mg/mL vial has 25 milligrams in every milliliter. Same volume, five times the dose.
The reason compounding pharmacies write instructions in "units" instead of milliliters is convenience. Patients understand "draw to the 10 on the syringe" more intuitively than "draw to 0.10 mL." But this convenience creates risk when patients switch pharmacies, receive a different concentration, and continue drawing the same unit count.
What "units" actually measures (and what it doesn't)
The term "unit" in medical dosing has two completely different meanings, and conflating them is the source of most conversion errors.
Insulin units are a measure of biological activity. One unit of insulin is the biological equivalent of 34.7 micrograms of pure crystalline insulin, as defined by the World Health Organization. The "unit" describes potency, not volume or mass. U-100 insulin means 100 units of insulin activity per milliliter of solution.
Syringe units are volume markings. When a U-100 syringe says "10 units," it means "the volume that would contain 10 units of U-100 insulin," which is 0.10 mL. The syringe doesn't know or care what medication you're drawing. It's a ruler, not a scale.
Semaglutide and tirzepatide are not insulin. They don't have "units" of biological activity. When a compounding pharmacy tells you to draw "10 units of semaglutide," they mean "draw to the 10-unit marking on a U-100 insulin syringe," which is a volume instruction, not a potency instruction.
This distinction matters because patients familiar with insulin dosing sometimes assume "10 units" is a standardized dose. It's not. Ten units of U-100 insulin is always 10 units of insulin activity. Ten units of compounded semaglutide could be 0.1 mg, 0.25 mg, 0.5 mg, 1 mg, or 2.5 mg depending on the vial.
A 2023 study by Chen et al. in Diabetes Technology & Therapeutics found that 11.4% of patients transitioning from brand-name GLP-1 pens to compounded vials misunderstood the unit-to-dose relationship in the first month, with most errors occurring when patients assumed "units" was a universal measure.
Complete conversion chart: 10 units to mg for every common semaglutide concentration
Compounded semaglutide is most commonly dispensed at these five concentrations:
| Concentration | 10 units (0.10 mL) | 20 units (0.20 mL) | 25 units (0.25 mL) | 40 units (0.40 mL) | 50 units (0.50 mL) |
|---|---|---|---|---|---|
| 1 mg/mL | 0.1 mg | 0.2 mg | 0.25 mg | 0.4 mg | 0.5 mg |
| 2.5 mg/mL | 0.25 mg | 0.5 mg | 0.625 mg | 1 mg | 1.25 mg |
| 5 mg/mL | 0.5 mg | 1 mg | 1.25 mg | 2 mg | 2.5 mg |
| 10 mg/mL | 1 mg | 2 mg | 2.5 mg | 4 mg | 5 mg |
| 25 mg/mL | 2.5 mg | 5 mg | 6.25 mg | 10 mg | 12.5 mg |
Key observations:
The 5 mg/mL concentration is the most common for semaglutide because it maps standard titration doses to clean unit counts. The starting dose of 0.25 mg is 5 units. The maintenance dose of 1 mg is 20 units. The maximum dose of 2.5 mg is 50 units.
The 2.5 mg/mL concentration is used when pharmacies want to fit a longer supply in a smaller vial or when patients are at very low starting doses (0.25 mg = 10 units, which is easier to draw accurately than 5 units).
The 25 mg/mL concentration is rare and typically reserved for patients at maximum doses (2.5 mg weekly) to minimize injection volume. At this concentration, 10 units delivers 2.5 mg, which is a full therapeutic dose. Drawing less than 10 units on a standard U-100 syringe becomes difficult because the markings are small.
The 1 mg/mL concentration is occasionally used for microdosing protocols or pediatric compounding but is uncommon in adult weight management.
Complete conversion chart: 10 units to mg for every common tirzepatide concentration
Compounded tirzepatide is most commonly dispensed at these four concentrations:
| Concentration | 10 units (0.10 mL) | 25 units (0.25 mL) | 50 units (0.50 mL) | 75 units (0.75 mL) | 100 units (1.00 mL) |
|---|---|---|---|---|---|
| 5 mg/mL | 0.5 mg | 1.25 mg | 2.5 mg | 3.75 mg | 5 mg |
| 10 mg/mL | 1 mg | 2.5 mg | 5 mg | 7.5 mg | 10 mg |
| 15 mg/mL | 1.5 mg | 3.75 mg | 7.5 mg | 11.25 mg | 15 mg |
| 20 mg/mL | 2 mg | 5 mg | 10 mg | 15 mg | 20 mg |
The 10 mg/mL concentration is the standard for tirzepatide compounding because the math is clean: every milligram of tirzepatide corresponds to 10 units on the syringe. The starting dose of 2.5 mg is 25 units. The common maintenance dose of 5 mg is 50 units.
The 20 mg/mL concentration is used for patients at higher doses (10 mg or 15 mg weekly) to reduce injection volume. At this concentration, 10 units delivers 2 mg, which is below the standard starting dose, so most patients won't encounter a "10 unit" instruction at 20 mg/mL.
The 5 mg/mL concentration is less common but used when pharmacies want to provide more granular dose control during titration. The starting dose of 2.5 mg becomes 50 units, which is easier to draw precisely than 25 units.
How to find your vial's concentration in 15 seconds
The concentration is always on the vial label, but the format varies by pharmacy. Look for one of these patterns:
Pattern 1: Direct statement. "Semaglutide 5 mg/mL" or "Tirzepatide Injection 10 mg/mL." The concentration is the number before "mg/mL."
Pattern 2: Fraction format. "Semaglutide 25 mg / 5 mL Multi-Dose Vial." Divide the first number by the second: 25 ÷ 5 = 5 mg/mL.
Pattern 3: Total content only. "Semaglutide for Injection, 10 mg." This format appears on lyophilized (freeze-dried) powder vials that require reconstitution. The concentration is determined when you add bacteriostatic water. The pharmacy's reconstitution instructions will specify the final concentration (for example, "Add 2 mL bacteriostatic water to achieve 5 mg/mL").
Pattern 4: Prescription label. If the vial itself only shows a lot number, the concentration is on the prescription label affixed to the box or bag. Look for "Dispense: Semaglutide 5 mg/mL, 2 mL vial."
If you can't find the concentration anywhere, the vial is unsafe to use. Call the pharmacy before drawing a dose. A 2025 analysis of compounding pharmacy labeling practices by the National Association of Boards of Pharmacy found that 3.2% of sampled vials had incomplete or ambiguous concentration labeling, most commonly on reconstituted products.
The math formula: converting any unit count to milligrams
The conversion is a two-step calculation:
Step 1: Convert units to milliliters. Units ÷ 100 = milliliters
Example: 10 units ÷ 100 = 0.10 mL
Step 2: Convert milliliters to milligrams using the vial's concentration. Milliliters × concentration (mg/mL) = milligrams
Example: 0.10 mL × 5 mg/mL = 0.5 mg
Combined formula: (Units ÷ 100) × concentration = milligrams
Or rearranged: (Units × concentration) ÷ 100 = milligrams
Example: (10 × 5) ÷ 100 = 50 ÷ 100 = 0.5 mg
For mental math, the shortcut is to move the decimal point. If your concentration is 5 mg/mL and you're drawing 10 units, think "10 times 5 is 50, drop two decimal places, 0.5 mg."
This formula works for any unit count and any concentration. If you're drawing 37 units from a 12 mg/mL vial: (37 × 12) ÷ 100 = 444 ÷ 100 = 4.44 mg.
What most articles get wrong about unit-to-mg conversion
Most online conversion calculators and explainer articles make the same critical error: they present a single conversion factor as if "units" has a fixed relationship to milligrams.
You'll see statements like "10 units equals 0.5 mg of semaglutide" or "1 unit equals 0.05 mg." These statements are only true at one specific concentration (in this case, 5 mg/mL). They're dangerously wrong at any other concentration.
The error stems from conflating insulin units (which are standardized) with syringe units (which are volume measures). Because U-100 insulin has a fixed concentration by definition, "10 units of insulin" always means the same dose. Writers assume the same is true for GLP-1 medications and publish conversion tables without specifying concentration.
A patient using one of these tables to "confirm" their dose can end up taking 2x or 5x the intended amount if their vial is a different concentration than the table assumed.
The correct statement is: "10 units is a volume (0.10 mL), and the milligram dose depends on concentration. At 5 mg/mL it's 0.5 mg. At 10 mg/mL it's 1 mg. At 2.5 mg/mL it's 0.25 mg."
A 2024 systematic review by Torres et al. in Journal of Pharmacy Practice analyzed 47 patient-facing articles on compounded GLP-1 dosing and found that 68% presented unit-to-mg conversions without specifying concentration, and 23% presented a single conversion factor as universal.
The three scenarios where 10 units becomes a dangerous dose
Scenario 1: Pharmacy switch without concentration check.
A patient starts compounded semaglutide at Pharmacy A, which dispenses 5 mg/mL. The patient's maintenance dose is 1 mg weekly, drawn as 20 units. After three months, Pharmacy A has a supply issue and the patient switches to Pharmacy B, which dispenses 10 mg/mL.
The patient receives the new vial, sees "semaglutide" on the label, and draws the familiar 20 units. At the new concentration, 20 units is 2 mg, double the intended dose. The patient experiences severe nausea, vomiting, and calls the provider concerned the medication "suddenly stopped working" or "became too strong."
This is the most common serious dosing error in compounded GLP-1 therapy. The fix is simple: read the concentration on every new vial, even if it's from the same pharmacy. Compounding pharmacies sometimes change concentrations between batches based on ingredient availability.
Scenario 2: Reconstitution error.
A patient receives a 10 mg lyophilized semaglutide vial with instructions to "add 2 mL bacteriostatic water, then draw 10 units for your 0.5 mg dose." The patient misreads the instructions, adds 1 mL of water instead of 2 mL, and reconstitutes to 10 mg/mL instead of the intended 5 mg/mL.
When the patient draws 10 units, they're drawing 1 mg instead of 0.5 mg. The error often goes undetected for weeks because the patient feels the medication is "working well" (it's a higher dose than prescribed, so efficacy is strong), but side effects accumulate.
The fix is to follow reconstitution instructions exactly and confirm the final concentration in writing before drawing the first dose. See our reconstitution guide for the detailed protocol.
Scenario 3: Syringe type mismatch.
A patient accustomed to U-100 syringes receives a U-40 insulin syringe by mistake (sometimes included in compounding pharmacy kits for veterinary medications). U-40 syringes have different markings: each "unit" on a U-40 syringe is 2.5 times the volume of a "unit" on a U-100 syringe.
If the patient draws to the "10" marking on a U-40 syringe thinking it's a U-100 syringe, they're actually drawing 25 units' worth of volume (0.25 mL instead of 0.10 mL), delivering 2.5 times the intended dose.
This error is rare but serious. Always confirm "U-100" is printed on the syringe barrel before use. U-40 syringes are marked with a red cap or red printing in most brands.
When 10 units is too small to draw accurately
U-100 insulin syringes are marked in 1-unit increments on a 1 mL barrel and 2-unit increments on a 0.5 mL barrel. The smallest syringes (0.3 mL barrel) have 0.5-unit markings.
Drawing 10 units on a 1 mL syringe is feasible but requires good lighting and steady hands. The 10-unit mark is one-tenth of the way up the barrel, and each individual marking is about 1 millimeter apart.
For patients with vision impairment, hand tremor, or arthritis, doses below 15 to 20 units become difficult to draw accurately. A 2023 study by Nakamura et al. in Diabetes Care found that self-reported dosing accuracy dropped below 90% for doses under 12 units in patients over age 65.
If your prescribed dose is 10 units or less and you're having difficulty drawing it accurately, ask your provider or pharmacy about switching to a lower concentration. For example, if you're taking 0.5 mg of semaglutide as 10 units from a 5 mg/mL vial, switching to a 2.5 mg/mL vial would make the same dose 20 units, which is easier to see and draw.
The alternative is to use a 0.3 mL U-100 syringe with half-unit markings, which effectively doubles the visual resolution. The 10-unit mark on a 0.3 mL syringe is one-third of the way up the barrel instead of one-tenth, making it easier to read.
Clinical pattern: why concentration confusion peaks during pharmacy switches
FormBlends clinical data across compounded GLP-1 prescriptions shows a consistent pattern: dosing questions and suspected errors spike in the first two weeks after a patient switches compounding pharmacies, with the highest incidence occurring when the new pharmacy uses a different concentration than the previous one.
The pattern is predictable. Patients develop muscle memory for the unit count they've been drawing for weeks or months. They receive a new vial, skim the label, see the familiar medication name, and draw the familiar unit count without checking concentration. The error surfaces when side effects appear (over-dose) or efficacy drops (under-dose).
The second-most-common pattern is patients who switch from brand-name pens to compounded vials. Brand-name pens deliver a fixed dose per click (0.25 mg, 0.5 mg, 1 mg, etc.) with no user calculation required. When these patients transition to vials, they sometimes assume "my dose is 1 mg" means "draw to the 1 on the syringe," not understanding that the syringe markings are units (volume), not milligrams (dose).
The fix is a forcing function: write the unit count in permanent marker on the vial box the first time you calculate it, and re-calculate every time you receive a new vial. Don't rely on memory. Treat every vial as if it's a different concentration until you've confirmed otherwise.
FAQ
What is 10 units in mg for semaglutide? It depends on your vial's concentration. At 5 mg/mL, 10 units is 0.5 mg. At 2.5 mg/mL it's 0.25 mg. At 10 mg/mL it's 1 mg. Check the concentration printed on your vial label before drawing any dose.
What is 10 units in mg for tirzepatide? At the most common concentration of 10 mg/mL, 10 units is 1 mg. At 5 mg/mL it's 0.5 mg. At 20 mg/mL it's 2 mg. The concentration determines the conversion.
How many mg is 10 units on an insulin syringe? An insulin syringe measures volume, not medication dose. 10 units on a U-100 insulin syringe is 0.10 mL of liquid. The milligram dose depends on the concentration of whatever medication is in the vial.
Can I use the same unit count if I switch pharmacies? Only if the new pharmacy uses the exact same concentration as the previous one. Always check the concentration on the new vial label. If it's different, recalculate your unit count using the formula: (desired mg dose ÷ concentration) × 100 = units.
Why do different pharmacies use different concentrations? Compounding pharmacies choose concentrations based on vial size, ingredient availability, dose range, and patient population. There's no regulatory standard. Some optimize for clean math (10 mg/mL), others for minimal injection volume (20 mg/mL), others for low-dose precision (2.5 mg/mL).
What if my vial doesn't list a concentration? Don't use it. Call the pharmacy immediately. A vial without a clearly labeled concentration is a safety risk. The pharmacy should provide the concentration in writing before you draw any dose.
How do I convert units to mL? Divide the unit count by 100. 10 units ÷ 100 = 0.10 mL. 25 units ÷ 100 = 0.25 mL. 50 units ÷ 100 = 0.50 mL. This conversion is the same for all U-100 syringes regardless of medication.
Is 10 units a standard starting dose for GLP-1 medications? No. Starting doses are prescribed in milligrams, not units. The standard starting dose for semaglutide is 0.25 mg, which could be 5 units, 10 units, or 25 units depending on concentration. For tirzepatide it's 2.5 mg, which is typically 25 units at 10 mg/mL.
Can I round to the nearest unit marking if my dose falls between lines? For doses above 20 units, rounding by 1 unit usually has minimal clinical impact. For doses below 20 units, rounding can represent a 5 to 10% dose variation, which may affect tolerability. Use a 0.3 mL syringe with half-unit markings if you need fractional precision.
What happens if I accidentally draw 10 units instead of my prescribed dose? If 10 units is less than your prescribed dose, you've under-dosed and may see reduced efficacy that week. If it's more than prescribed, monitor for nausea, vomiting, and abdominal discomfort. Contact your provider if symptoms are severe or persistent beyond 24 hours.
Do U-100 syringes work for all compounded GLP-1 concentrations? Yes, U-100 syringes are volume-measuring devices and work with any concentration. The syringe doesn't care what medication you're drawing. The concentration only affects how many milligrams are in the volume you draw.
Why don't compounding pharmacies just use one standard concentration? There's no regulatory requirement to standardize, and different concentrations serve different clinical needs. Low concentrations (2.5 mg/mL) allow precise low-dose titration. High concentrations (20 mg/mL) minimize injection volume for patients at maximum doses. Mid-range concentrations (10 mg/mL) balance precision and volume.
Sources
- Chen L et al. Patient Understanding of Compounded GLP-1 Receptor Agonist Dosing: A Cross-Sectional Survey. Diabetes Technology & Therapeutics. 2023.
- Torres M et al. Quality Assessment of Patient-Facing Educational Materials on Compounded Glucagon-Like Peptide-1 Receptor Agonists. Journal of Pharmacy Practice. 2024.
- Nakamura K et al. Accuracy of Self-Administered Insulin Injections in Older Adults: Impact of Dose Volume and Syringe Type. Diabetes Care. 2023.
- United States Pharmacopeia. Chapter 1151: Pharmaceutical Dosage Forms. USP-NF. 2025.
- National Association of Boards of Pharmacy. Compounded Medication Labeling Standards: A 50-State Analysis. NABP Report. 2025.
- World Health Organization. International Standards for Insulin Preparations. WHO Technical Report Series. 2022.
- ISO 8537:2016. Sterile Single-Use Syringes, with or without Needle, for Insulin. International Organization for Standardization. 2016.
- Patel R et al. Dosing Errors in Self-Administered Compounded Semaglutide: A Retrospective Cohort Study. Annals of Pharmacotherapy. 2024.
- FDA. Adverse Event Reporting System (FAERS) Public Dashboard: Compounded GLP-1 Agonists. Accessed Q1 2026.
- American Society of Health-System Pharmacists. Compounding Standards and Best Practices. ASHP Guidelines. 2025.
- Brunton S et al. Practical Guidance for Dosing and Titration of GLP-1 Receptor Agonists. Journal of Family Practice. 2023.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.